Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A critical review of laboratory performance indicators.
Tsai ER, Tintu AN, Demirtas D, Boucherie RJ, de Jonge R, de Rijke YB. Tsai ER, et al. Among authors: tintu an. Crit Rev Clin Lab Sci. 2019 Nov;56(7):458-471. doi: 10.1080/10408363.2019.1641789. Epub 2019 Aug 8. Crit Rev Clin Lab Sci. 2019. PMID: 31393193 Review.
Real-time monitoring of drug laboratory test interactions: a proof of concept.
van Balveren JA, Verboeket-van de Venne WPHG, Doggen CJM, Erdem-Eraslan L, de Graaf AJ, Krabbe JG, Musson REA, Oosterhuis WP, de Rijke YB, van der Sijs H, Tintu AN, Verheul RJ, Hoedemakers RMJ, Kusters R. van Balveren JA, et al. Among authors: tintu an. Clin Chem Lab Med. 2021 Nov 9;60(2):235-242. doi: 10.1515/cclm-2021-0790. Print 2022 Jan 27. Clin Chem Lab Med. 2021. PMID: 34751523
Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis.
Noori S, Zajec M, Russcher H, Tintu AN, Broijl A, Jacobs JFM, Luider TM, de Rijke YB, vanDuijn MM. Noori S, et al. Among authors: tintu an. Hemasphere. 2022 Aug 2;6(8):e758. doi: 10.1097/HS9.0000000000000758. eCollection 2022 Aug. Hemasphere. 2022. PMID: 35935609 Free PMC article. No abstract available.
Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey.
van Balveren JA, Verboeket-van de Venne WPHG, Doggen CJM, Cornelissen AS, Erdem-Eraslan L, de Graaf AJ, Krabbe JG, Musson REA, Oosterhuis WP, de Rijke YB, van der Sijs H, Tintu AN, Verheul RJ, Hoedemakers RMJ, Kusters R; Dutch Society for Clinical Chemistry and Laboratory Medicine; task group ‘SMILE’: Signaling Medication Interactions and Laboratory test Expert system. van Balveren JA, et al. Among authors: tintu an. Clin Chem Lab Med. 2021 Feb 25;59(7):1239-1245. doi: 10.1515/cclm-2020-1770. Print 2021 Jun 25. Clin Chem Lab Med. 2021. PMID: 33645171
Symptomatic rebound methaemoglobinaemia after treatment with dapsone.
Jonkers BRP, Cobanoglu G, Blok EJ, Köbben JJ, van der Helm MW, van Hoof IJAM, Tintu AN, Bethlehem C, Versmissen J. Jonkers BRP, et al. Among authors: tintu an. Neth J Med. 2020 Sep;78(5):277-281. Neth J Med. 2020. PMID: 33093248 Free article.
Added value of drug-laboratory test interaction alerts in test result authorisation.
van Balveren JA, Verboeket-van de Venne WPHG, Doggen CJM, Erdem-Eraslan L, de Graaf AJ, Krabbe JG, Musson REA, Oosterhuis WP, de Rijke YB, van der Sijs H, Tintu AN, Verheul RJ, Hoedemakers RMJ, Kusters R. van Balveren JA, et al. Among authors: tintu an. Clin Chem Lab Med. 2022 Feb 18;60(5):e108-e111. doi: 10.1515/cclm-2022-0077. Print 2022 Apr 26. Clin Chem Lab Med. 2022. PMID: 35184434 No abstract available.
17 results